INTELLIA THERAPEUTICS INC (NTLA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NTLA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NTLA | ["Product Development and/or Commercialization","Drug Discovery Research"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Cohen served on the compensation committee throughout 2025 and on the science and technology committee throughout 2025. Our board of directors has determined that Dr. Cohen is independent as defined in the applicable SEC and Nasdaq rules.